What is the second Chinese company win experts approval for flu vaccine?
Second Chinese company wins experts’ approval for A(H1N1) flu vaccine September 1, 2009 10:29 am BEIJING, Sept. 1 — The vaccine for the A(H1N1) influenza produced by Chinese pharmaceutical company Hualan Biological Engineering Inc. on Tuesday passed an expert evaluation organized by the State Food and Drug Administration (SFDA). Hualan’s flu vaccine could safely be given to people aged above three in a single shot, 15 microgram dose, and was approved by the unanimous vote of 41 experts after they studied the recent adverse drug reactions of the vaccine. The experts will submit a report to the SFDA which will make the final decision in three days. Should the SFDA greenlight Hualan’s vaccine, the company would get its production license for the drug this week. It made Hualan the second Chinese company to gain approval from the SFDA expert team over the A(H1N1) influenza vaccine. On Monday, the experts approved flu vaccines produced by Sinovac Biotech Ltd., or the Beijing Kexing Bioproduc
Hualan Biological Engineering Inc. on Tuesday passed an expert evaluation organized by the State Food and Drug Administration (SFDA). Hualan’s flu vaccine could safely be given to people aged above three in a single shot, 15 microgram dose, and was approved by the unanimous vote of 41 experts after they studied the recent adverse drug reactions of the vaccine. The experts will submit a report to the SFDA which will make the final decision in three days. Should the SFDA greenlight Hualan’s vaccine, the company would get its production license for the drug this week. It made Hualan the second Chinese company to gain approval from the SFDA expert team over the A/H1N1 influenza vaccine. On Monday, the experts approved flu vaccines produced by Sinovac Biotech Ltd., or the Beijing Kexing Bioproducts. However, Sinovac’s vaccines were only approved to be given to three- to 60-year-olds. Hualan was among the first companies in China to receive the seed virus of the A/H1N1 flu for vaccine produc
BEIJING, Sept. 1 (Xinhua) — The vaccine for the A/H1N1 influenza produced by Chinese pharmaceutical company Hualan Biological Engineering Inc. on Tuesday passed an expert evaluation organized by the State Food and Drug Administration (SFDA). Hualan’s flu vaccine could safely be given to people aged above three in a single shot, 15 microgram dose, and was approved by the unanimous vote of 41 experts after they studied the recent adverse drug reactions of the vaccine. The experts will submit a report to the SFDA which will make the final decision in three days. Should the SFDA greenlight Hualan’s vaccine, the company would get its production license for the drug this week. Sources: http://news.xinhuanet.com/english/2009-09/01/content_11979690.
